This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune disease that affects the bile ducts of the liver. It is caused by an autoimmune process, in which the body’s immune system mistakenly attacks and destroys the bile ducts, causing damage to the liver that results in inflammation and scarring. In the early stages of the disease, the liver has difficulty getting rid of bile, which can lead to a buildup of bile acids in the bloodstream. This buildup of bile acids can result in itching, fatigue, and jaundice. As the disease progresses, scarring of the liver can occur, leading to cirrhosis and liver failure. Treatment for PBC typically involves medications such as ursodeoxycholic acid (UDCA) and corticosteroids to reduce inflammation and slow the progression of the disease. In addition, lifestyle modifications such as avoiding alcohol and maintaining a healthy weight are recommended. In some cases, a liver transplant may be necessary to restore liver function. PBC can be difficult to diagnose because its symptoms can be similar to other liver diseases. Diagnosis usually involves blood tests, imaging tests, and a biopsy of the liver. Early diagnosis and treatment can help slow the progression of the disease and reduce the risk of complications. It is important to talk to your doctor if you experience any of the symptoms of PBC, as early diagnosis and treatment can help slow the progression of the disease.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States